Content about Ranbaxy Pharmaceuticals

November 30, 2010

Ranbaxy Pharmaceuticals has received final approval for its generic Alzheimer's drug from the Food and Drug Administration, giving the drug maker 180 days of market exclusivity.

© 2014 Drug Store News. All Rights Reserved.